Inhibition of Brain Phospholipase A2 by Antimalarial Drugs: Implications for Neuroprotection in Neurological Disorders

By  

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 5, 2005-10 ,pp. : 379-392

Bentham Science Publishers

Access to resources Recommend Favorite

Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

By Bozikas V.P.   Papakosta M.   Niopas I.   Karavatos A.   Mirtsou-Fidani V.  

European Neuropsychopharmacology, Vol. 14, Iss. 1, 2004-01 ,pp. : 39-44

Elsevier

Access to resources Recommend Favorite

Brain phospholipase A 2 -arachidonic acid cascade is involved in the activation of central sympatho-adrenomedullary outflow in rats

By Yokotani K.   Wang M.   Murakami Y.   Okada S.   Hirata M.  

European Journal of Pharmacology, Vol. 398, Iss. 3, 2000-06 ,pp. : 341-347

Elsevier

Access to resources Recommend Favorite

Chronic fluoxetine increases cytosolic phospholipase A₂ activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat

By Lee Ho-Joo   Rao Jagadeesh   Ertley Renee   Chang Lisa   Rapoport Stanley   Bazinet Richard  

Psychopharmacology, Vol. 190, Iss. 1, 2007-01 ,pp. : 103-115

Springer Publishing Company

Access to resources Recommend Favorite

Phospholipase A2 inhibitors in development

By Friebe U.W-G.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 3, 1997-03 ,pp. : 279-298

Informa Healthcare

Access to resources Recommend Favorite